{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T17:23:00Z","timestamp":1774977780426,"version":"3.50.1"},"reference-count":51,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health\n              https:\/\/ror.org\/01cwqze88","doi-asserted-by":"publisher","award":["CA283524"],"award-info":[{"award-number":["CA283524"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health\n              https:\/\/ror.org\/01cwqze88","doi-asserted-by":"publisher","award":["AI179337"],"award-info":[{"award-number":["AI179337"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UNTHSC\n              https:\/\/ror.org\/05msxaq47"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Hepatitis C virus (HCV) infection is a significant contributor to the development of hepatocellular carcinoma (HCC). One mechanism by which HCV promotes HCC is the remodeling of host cell metabolism; however, the molecular mediators of this process are not yet fully understood. In this study, we identified Hexokinase Domain-Containing Protein 1 (HKDC1) as a crucial effector that links HCV infection to glycolytic reprogramming in hepatoma cells. HCV-positive APC140 cells showed selective upregulation of HKDC1, accompanied by enhanced cytoplasmic localization of the protein. Moreover, these cells exhibited increased total hexokinase activity and elevated pyruvate and lactate production, while the classical hexokinases HK1, HK2, HK3, and HK4 remained unchanged. Depleting HKDC1 led to a reduction in hexokinase activity, glycolytic flux, and HCV subgenomic replicon-associated reporter activity, with no compensatory changes noted in other members of the hexokinase family. These findings indicate that HCV-induced HKDC1 creates a metabolic environment conducive to viral replication and may contribute to HCC development. Therefore, HKDC1 acts as a virus-responsive metabolic mediator that links chronic HCV infection to oncogenic metabolic reprogramming, positioning it as a potential therapeutic target in HCV-associated HCC.<\/jats:p>","DOI":"10.3390\/v18040423","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T16:34:08Z","timestamp":1774974848000},"page":"423","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hepatitis C Virus (HCV)\u2014Mediated Activation of Hexokinase Domain-Containing Protein 1 (HKDC1) Promotes Hexokinase Activity and Metabolic Reprogramming"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-2593-8129","authenticated-orcid":false,"given":"Hope K.","family":"Fiadjoe","sequence":"first","affiliation":[{"name":"Department of Microbiology, Immunology, and Genetics, University of North Texas Health Science Center, Fort Worth, TX 76107, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amani","family":"Doyle","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Immunology, and Genetics, University of North Texas Health Science Center, Fort Worth, TX 76107, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In-Woo","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Immunology, and Genetics, University of North Texas Health Science Center, Fort Worth, TX 76107, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pankaj","family":"Chaudhary","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Immunology, and Genetics, University of North Texas Health Science Center, Fort Worth, TX 76107, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","article-title":"Global trends in hepatocellular carcinoma epidemiology: Implications for screening, prevention and therapy","volume":"20","author":"Singal","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.cell.2017.05.046","article-title":"Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma","volume":"169","author":"Ally","year":"2017","journal-title":"Cell"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/hep.31288","article-title":"Epidemiology of Hepatocellular Carcinoma","volume":"73","author":"McGlynn","year":"2021","journal-title":"Hepatology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","article-title":"Epidemiology of viral hepatitis and hepatocellular carcinoma","volume":"142","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"224","DOI":"10.2174\/1389200219666180129110942","article-title":"Hepatitis C Virus Mediated Metastasis in Hepatocellular Carcinoma as a Therapeutic Target for Cancer Management","volume":"19","author":"Khera","year":"2018","journal-title":"Curr. Drug Metab."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Ninio, L., Nissani, A., Meirson, T., Domovitz, T., Genna, A., Twafra, S., Srikanth, K.D., Dabour, R., Avraham, E., and Davidovich, A. (2019). Hepatitis C Virus Enhances the Invasiveness of Hepatocellular Carcinoma via EGFR-Mediated Invadopodia Formation and Activation. Cells, 8.","DOI":"10.3390\/cells8111395"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nrmicro3046","article-title":"The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection","volume":"11","author":"Bartenschlager","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: The metabolic requirements of cell proliferation","volume":"324","author":"Cantley","year":"2009","journal-title":"Science"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1128\/JVI.02862-13","article-title":"Activity of hexokinase is increased by its interaction with hepatitis C virus protein NS5A","volume":"88","author":"Rodriguez","year":"2014","journal-title":"J. Virol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Perrin-Cocon, L., Kundlacz, C., Jacquemin, C., Hanoulle, X., Aublin-Gex, A., Figl, M., Manteca, J., Andr\u00e9, P., Vidalain, P.O., and Lotteau, V. (2022). Domain 2 of Hepatitis C Virus Protein NS5A Activates Glucokinase and Induces Lipogenesis in Hepatocytes. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23020919"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1002\/jmv.24498","article-title":"Differential association of STAT3 and HK-II expression in hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma","volume":"88","author":"Li","year":"2016","journal-title":"J. Med. Virol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Farooq, Z., Ismail, H., Bhat, S.A., Layden, B.T., and Khan, M.W. (2023). Aiding Cancer\u2019s \u201cSweet Tooth\u201d: Role of Hexokinases in Metabolic Reprogramming. Life, 13.","DOI":"10.20944\/preprints202303.0440.v1"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"100077","DOI":"10.1016\/j.cellin.2023.100077","article-title":"Hexokinases in cancer and other pathologies","volume":"2","author":"Guo","year":"2023","journal-title":"Cell Insight"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1038\/s41375-020-0801-5","article-title":"HKDC1 C-terminal based peptides inhibit extranodal natural killer\/T-cell lymphoma by modulation of mitochondrial function and EBV suppression","volume":"34","author":"Chen","year":"2020","journal-title":"Leukemia"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.tem.2021.10.006","article-title":"Hexokinase domain-containing protein-1 in metabolic diseases and beyond","volume":"33","author":"Zapater","year":"2022","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"8034","DOI":"10.1038\/s41598-023-33924-3","article-title":"Liver-specific overexpression of HKDC1 increases hepatocyte size and proliferative capacity","volume":"13","author":"Pusec","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1210\/en.2018-00887","article-title":"Hepatic HKDC1 Expression Contributes to Liver Metabolism","volume":"160","author":"Pusec","year":"2019","journal-title":"Endocrinology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e2306454120","DOI":"10.1073\/pnas.2306454120","article-title":"HKDC1, a target of TFEB, is essential to maintain both mitochondrial and lysosomal homeostasis, preventing cellular senescence","volume":"121","author":"Cui","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/s12935-020-01539-7","article-title":"HKDC1 promotes the tumorigenesis and glycolysis in lung adenocarcinoma via regulating AMPK\/mTOR signaling pathway","volume":"20","author":"Wang","year":"2020","journal-title":"Cancer Cell Int."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Huang, G., Zhang, J., Gong, L., Huang, Y., and Liu, D. (2021). A glycolysis-based three-gene signature predicts survival in patients with lung squamous cell carcinoma. BMC Cancer, 21.","DOI":"10.1186\/s12885-021-08360-z"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1002\/cam4.3945","article-title":"Identification of a glycolysis-related gene signature associated with clinical outcome for patients with lung squamous cell carcinoma","volume":"10","author":"Xu","year":"2021","journal-title":"Cancer Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1002\/jcp.25846","article-title":"A prognostic 4-gene expression signature for squamous cell lung carcinoma","volume":"232","author":"Li","year":"2017","journal-title":"J. Cell. Physiol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Chen, X., Lv, Y., Sun, Y., Zhang, H., Xie, W., Zhong, L., Chen, Q., Li, M., Li, L., and Feng, J. (2019). PGC1\u03b2 Regulates Breast Tumor Growth and Metastasis by SREBP1-Mediated HKDC1 Expression. Front. Oncol., 9.","DOI":"10.3389\/fonc.2019.00290"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"148752","DOI":"10.1016\/j.gene.2024.148752","article-title":"HNF1\u03b1 promotes colorectal cancer progression via HKDC1-mediated activation of AKT\/AMPK signaling pathway","volume":"928","author":"Yang","year":"2024","journal-title":"Gene"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12967-023-03983-1","article-title":"Lactoferrin suppresses the progression of colon cancer under hyperglycemia by targeting WTAP\/m(6)A\/NT5DC3\/HKDC1 axis","volume":"21","author":"Li","year":"2023","journal-title":"J. Transl. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1111\/cas.15692","article-title":"HKDC1 upregulation promotes glycolysis and disease progression, and confers chemoresistance onto gastric cancer","volume":"114","author":"Wang","year":"2023","journal-title":"Cancer Sci."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Yang, Y., Xie, L., Li, C., Liu, L., Ye, X., and Han, J. (2022). Prognostic Model of Eleven Genes Based on the Immune Microenvironment in Patients With Thymoma. Front. Genet., 13.","DOI":"10.3389\/fgene.2022.668696"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s13258-017-0518-7","article-title":"MicroRNA expression patterns and target prediction in multiple myeloma development and malignancy","volume":"39","author":"Bong","year":"2017","journal-title":"Genes Genom."},{"key":"ref_31","first-page":"4157","article-title":"Whole-exome sequencing revealed HKDC1 as a candidate gene associated with autosomal-recessive retinitis pigmentosa","volume":"27","author":"Zhang","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1097\/HEP.0000000000001085","article-title":"HKDC1 promotes liver cancer stemness under hypoxia through stabilizing \u03b2-catenin","volume":"81","author":"Fan","year":"2025","journal-title":"Hepatology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1053\/j.gastro.2020.12.008","article-title":"Integrated Multiomics Reveals Glucose Use Reprogramming and Identifies a Novel Hexokinase in Alcoholic Hepatitis","volume":"160","author":"Massey","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.bbrc.2016.05.007","article-title":"High expression of hexokinase domain containing 1 is associated with poor prognosis and aggressive phenotype in hepatocarcinoma","volume":"474","author":"Zhang","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1038\/s41467-024-45712-2","article-title":"HKDC1 promotes tumor immune evasion in hepatocellular carcinoma by coupling cytoskeleton to STAT1 activation and PD-L1 expression","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Whitmill, A., Kim, S., Rojas, V., Gulraiz, F., Afreen, K., Jain, M., Singh, M., and Park, I.W. (2018). Signature molecules expressed differentially in a liver disease stage-specific manner by HIV-1 and HCV co-infection. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0202524"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"199593","DOI":"10.1016\/j.virusres.2025.199593","article-title":"Validation of signature molecular profiles of advanced HCV liver disease in hepatocellular carcinoma patients","volume":"357","author":"Park","year":"2025","journal-title":"Virus Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1007\/s12672-025-04043-4","article-title":"Histidine ammonia lyase expression characteristics in primary liver cancer: Hepatocellular carcinoma and cholangiocarcinoma","volume":"16","author":"Fiadjoe","year":"2025","journal-title":"Discov. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Diaz, O., Vidalain, P.-O., Rami\u00e8re, C., Lotteau, V., and Perrin-Cocon, L. (2022). What role for cellular metabolism in the control of hepatitis viruses?. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1033314"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Li, H., Lin, C., Qi, W., Sun, Z., Xie, Z., Jia, W., and Ning, Z. (2023). Senecavirus A-induced glycolysis facilitates virus replication by promoting lactate production that attenuates the interaction between MAVS and RIG-I. PLoS Pathog., 19.","DOI":"10.1371\/journal.ppat.1011371"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/j.jhep.2014.07.010","article-title":"Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma","volume":"61","author":"Hoshida","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1021\/acschembio.5c00715","article-title":"Characterization and Inhibition of Human Hexokinase Domain Containing Protein 1 Reveals an Enzyme with Unique Catalytic and Regulatory Traits","volume":"20","author":"Piwko","year":"2025","journal-title":"ACS Chem. Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/s41419-022-04999-z","article-title":"The hexokinase \u201cHKDC1\u201d interaction with the mitochondria is essential for liver cancer progression","volume":"13","author":"Khan","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"115250","DOI":"10.1016\/j.celrep.2025.115250","article-title":"Nuclear-localized HKDC1 promotes hepatocellular carcinoma through phosphorylating RBBP5 to upregulate H3K4me3","volume":"44","author":"Ye","year":"2025","journal-title":"Cell Rep."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1242\/jcs.089110","article-title":"Protein localization in disease and therapy","volume":"124","author":"Hung","year":"2011","journal-title":"J. Cell Sci."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Thaker, S.K., Ch\u2019ng, J., and Christofk, H.R. (2019). Viral hijacking of cellular metabolism. BMC Biol., 17.","DOI":"10.1186\/s12915-019-0678-9"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Varanasi, S.K., Jaggi, U., Hay, N., and Rouse, B.T. (2018). Hexokinase II may be dispensable for CD4 T cell responses against a virus infection. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0191533"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ccr.2013.06.014","article-title":"Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer","volume":"24","author":"Patra","year":"2013","journal-title":"Cancer Cell"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/nrd942","article-title":"Hepatitis C virus replicons: Potential role for drug development","volume":"1","author":"Bartenschlager","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0006-291X(02)00342-X","article-title":"Subgenomic replicon derived from a cell line infected with the hepatitis C virus","volume":"293","author":"Kishine","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12575-025-00318-w","article-title":"Molecular regulatory network of glycolytic reprogramming in hepatocellular carcinoma and its clinical implications","volume":"27","author":"Zhu","year":"2025","journal-title":"Biol. Proced. Online"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/4\/423\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T16:36:50Z","timestamp":1774975010000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/4\/423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":51,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["v18040423"],"URL":"https:\/\/doi.org\/10.3390\/v18040423","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]}}}